FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113166412> ?p ?o ?g. }

• W3113166412 endingPage "338" @default.
• W3113166412 startingPage "338" @default.
• W3113166412 abstract "The development and expansion of intracranial hematoma are associated with adverse outcomes. Use of tranexamic acid might limit intracranial hematoma formation, but its association with outcomes of severe traumatic brain injury (TBI) is unclear.To assess whether prehospital administration of tranexamic acid is associated with mortality and functional outcomes in a group of patients with severe TBI.This multicenter cohort study is an analysis of prospectively collected observational data from the Brain Injury: Prehospital Registry of Outcome, Treatments and Epidemiology of Cerebral Trauma (BRAIN-PROTECT) study in the Netherlands. Patients treated for suspected severe TBI by the Dutch Helicopter Emergency Medical Services between February 2012 and December 2017 were included. Patients were followed up for 1 year after inclusion. Data were analyzed from January 10, 2020, to September 10, 2020.Administration of tranexamic acid during prehospital treatment.The primary outcome was 30-day mortality. Secondary outcomes included mortality at 1 year, functional neurological recovery at discharge (measured by Glasgow Outcome Scale), and length of hospital stay. Data were also collected on demographic factors, preinjury medical condition, injury characteristics, operational characteristics, and prehospital vital parameters.A total of 1827 patients were analyzed, of whom 1283 (70%) were male individuals and the median (interquartile range) age was 45 (23-65) years. In the unadjusted analysis, higher 30-day mortality was observed in patients who received prehospital tranexamic acid (odds ratio [OR], 1.34; 95% CI, 1.16-1.55; P < .001), compared with patients who did not receive prehospital tranexamic acid. After adjustment for confounders, no association between prehospital administration of tranexamic acid and mortality was found across the entire cohort of patients. However, a substantial increase in the odds of 30-day mortality persisted in patients with severe isolated TBI who received prehospital tranexamic acid (OR, 4.49; 95% CI, 1.57-12.87; P = .005) and after multiple imputations (OR, 2.05; 95% CI, 1.22-3.45; P = .007).This study found that prehospital tranexamic acid administration was associated with increased mortality in patients with isolated severe TBI, suggesting the judicious use of the drug when no evidence for extracranial hemorrhage is present." @default.
• W3113166412 created "2020-12-21" @default.
• W3113166412 creator A5001096385 @default.
• W3113166412 creator A5001197145 @default.
• W3113166412 creator A5009033968 @default.
• W3113166412 creator A5015764426 @default.
• W3113166412 creator A5016184040 @default.
• W3113166412 creator A5020455963 @default.
• W3113166412 creator A5025324690 @default.
• W3113166412 creator A5026269075 @default.
• W3113166412 creator A5027059903 @default.
• W3113166412 creator A5028975454 @default.
• W3113166412 creator A5030249422 @default.
• W3113166412 creator A5032773132 @default.
• W3113166412 creator A5034321427 @default.
• W3113166412 creator A5035016572 @default.
• W3113166412 creator A5035267054 @default.
• W3113166412 creator A5038969390 @default.
• W3113166412 creator A5040462237 @default.
• W3113166412 creator A5041756655 @default.
• W3113166412 creator A5042999403 @default.
• W3113166412 creator A5044853140 @default.
• W3113166412 creator A5046484053 @default.
• W3113166412 creator A5055108877 @default.
• W3113166412 creator A5055869696 @default.
• W3113166412 creator A5056460342 @default.
• W3113166412 creator A5056811062 @default.
• W3113166412 creator A5058521952 @default.
• W3113166412 creator A5063847793 @default.
• W3113166412 creator A5064012416 @default.
• W3113166412 creator A5064991429 @default.
• W3113166412 creator A5068938025 @default.
• W3113166412 creator A5070941553 @default.
• W3113166412 creator A5071173512 @default.
• W3113166412 creator A5073463366 @default.
• W3113166412 creator A5077516164 @default.
• W3113166412 creator A5080121473 @default.
• W3113166412 creator A5081049784 @default.
• W3113166412 creator A5082499950 @default.
• W3113166412 creator A5090049970 @default.
• W3113166412 creator A5090372656 @default.
• W3113166412 creator A5091288297 @default.
• W3113166412 date "2021-03-01" @default.
• W3113166412 modified "2023-10-15" @default.
• W3113166412 title "Association Between Prehospital Tranexamic Acid Administration and Outcomes of Severe Traumatic Brain Injury" @default.
• W3113166412 cites W1982305254 @default.
• W3113166412 cites W2068039646 @default.
• W3113166412 cites W2113412798 @default.
• W3113166412 cites W2123578204 @default.
• W3113166412 cites W2157874665 @default.
• W3113166412 cites W2162132892 @default.
• W3113166412 cites W2162249417 @default.
• W3113166412 cites W2173352997 @default.
• W3113166412 cites W2275737843 @default.
• W3113166412 cites W2390102805 @default.
• W3113166412 cites W2440977308 @default.
• W3113166412 cites W2545458768 @default.
• W3113166412 cites W2562481671 @default.
• W3113166412 cites W2607870311 @default.
• W3113166412 cites W2624237577 @default.
• W3113166412 cites W2803869263 @default.
• W3113166412 cites W2808424035 @default.
• W3113166412 cites W2883412079 @default.
• W3113166412 cites W2887265841 @default.
• W3113166412 cites W2904294604 @default.
• W3113166412 cites W2924841476 @default.
• W3113166412 cites W2971722357 @default.
• W3113166412 cites W2985500184 @default.
• W3113166412 cites W2996383390 @default.
• W3113166412 cites W3008228279 @default.
• W3113166412 cites W3042955173 @default.
• W3113166412 cites W3084265249 @default.
• W3113166412 cites W3089242486 @default.
• W3113166412 cites W3093671858 @default.
• W3113166412 cites W4211043869 @default.
• W3113166412 cites W4245982419 @default.
• W3113166412 doi "https://doi.org/10.1001/jamaneurol.2020.4596" @default.
• W3113166412 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7953275" @default.
• W3113166412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33284310" @default.
• W3113166412 hasPublicationYear "2021" @default.
• W3113166412 type Work @default.
• W3113166412 sameAs 3113166412 @default.
• W3113166412 citedByCount "34" @default.
• W3113166412 countsByYear W31131664122021 @default.
• W3113166412 countsByYear W31131664122022 @default.
• W3113166412 countsByYear W31131664122023 @default.
• W3113166412 crossrefType "journal-article" @default.
• W3113166412 hasAuthorship W3113166412A5001096385 @default.
• W3113166412 hasAuthorship W3113166412A5001197145 @default.
• W3113166412 hasAuthorship W3113166412A5009033968 @default.
• W3113166412 hasAuthorship W3113166412A5015764426 @default.
• W3113166412 hasAuthorship W3113166412A5016184040 @default.
• W3113166412 hasAuthorship W3113166412A5020455963 @default.
• W3113166412 hasAuthorship W3113166412A5025324690 @default.
• W3113166412 hasAuthorship W3113166412A5026269075 @default.
• W3113166412 hasAuthorship W3113166412A5027059903 @default.
• W3113166412 hasAuthorship W3113166412A5028975454 @default.
• W3113166412 hasAuthorship W3113166412A5030249422 @default.

• next